Thomas Schinecker, CEO of Roche, leads one of the world’s largest healthcare companies with a mission to advance personalized medicine and redefine cancer treatment. Under his leadership, Roche has been at the forefront of integrating AI in drug discovery and diagnostics, driving innovation in precision medicine. With a PhD in molecular biology and decades of experience in the pharmaceutical industry, Schinecker is a champion of R&D excellence and global collaboration. His vision extends to tackling challenges in clinical trials and ensuring Europe remains competitive amidst China's healthcare advancements.